Layer3.news

AI by layer3.news

Filtering by: Evan Seigerman · clear filter

BMO BELIEVES MARKET UNDERVALUES TERNS PHARMACEUTICALS (TERN) DESPITE STRONG TRIAL DATA

https://media.zenfs.com/en/insidermonkey.com/ff549bd3d58c48b34c03df19e399eeac

✍️ Terns Pharmaceuticals Inc. (NASDAQ:TERN) is a hot SMID-cap stock in 2025, with a recent price target increase from $22 to $30 by BMO Capital Markets.

👉 BMO Capital Markets raised price target on Terns Pharmaceuticals Inc. (NASDAQ:TERN) from $22 to $30 👉 TERN-701 showed clear differentiation from current treatment options in Phase 1 CARDINAL data 👉 64% molecular response rate by 24 weeks in patients with resistant or relapsed chronic myeloid leukemia (CML) 👉 Company will present additional data at the 67th Annual Meeting of the American Society of Hematology (ASH) in December

-- #EvanSeigerman #AmyBurroughs #Orlando,Florida #business

Loading quoted post…

nostr:nevent1qvzqqqqqqypzqe6z4eqs8a86awpjvnv4ta6zlxnprtyqryxvqpp78vezxxxv0mnpqyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq04xenwd8h4urleha6dl0n6j6vu4n8u4wxgmegm87f5u2ct3gxq9q6m5qqv

Evan Seigerman Amy Burroughs Orlando, Florida business mainstream:perspective

Layer3.news

✍️ Terns Pharmaceuticals Inc. (NASDAQ:TERN) is a hot SMID-cap stock in 2025, with a recent price target increase from $22 to $30 by BMO Capital Markets.

-- #EvanSeigerman #AmyBurroughs #Orlando,Florida #business

✍️ Eli Lilly becomes the first drugmaker to reach a market value of $1 trillion, driven by its success in the weight-loss market.

-- #EvanSeigerman #HankSmith #SiddhiMahatole #ShashwatChauhan #LeroyLeo #Bengaluru #business

✍️ Novo Nordisk A/S (NYSE:NVO) has lowered the US prices of its injectable Wegovy obesity drug, with the CEO pledging to 'go all in' with its upcoming oral weight-loss pill.

-- #MikeDoustdar #EvanSeigerman #KerryHolford #business

✍️ Vertex Pharmaceuticals' third quarter revenue grew by 11% year-on-year, driven by the expansion of its cystic fibrosis franchise and new launches in acute pain and genetic therapies.

-- #ReshmaKewalramani #GeoffreyMeacham #SalveenRichter #JessicaFye #EvanSeigerman #TazeenAhmad #CharlesWagner #DuncanMcKechnie #business

✍️ AbbVie's shares dropped 4% after reporting a 3.7% decline in quarterly sales of its aesthetic products, including Botox, while the company raised its 2025 profit forecast due to strong sales of immunology drugs Skyrizi and Rinvoq.

-- #PatrickWingrove #PuyaanSingh #ScottReents #EvanSeigerman #JeffreyStewart #CourtneyBreen #DonaldTrump #JoeBiden #NorthChicago #NewYork #Bengaluru #business

✍️ AbbVie raised its 2025 profit forecast after strong sales of immunology drugs Skyrizi and Rinvoq, but shares fell due to declining sales of its aesthetics products portfolio.

-- #EvanSeigerman #JeffreyStewart #CourtneyBreen #business

✍️ Eli Lilly and Novo Nordisk, two obesity drug giants, are preparing to release their quarterly results, but investors are more focused on the companies' potential price talks with US President Donald Trump.

-- #EvanSeigerman #PaulMajor #JamesShin #DonaldTrump #MrinalikaRoy #BhanviSatija #MaggieFick #Bengaluru #London #US #business

✍️ Bristol Myers Squibb acquires Orbital Therapeutics for $1.5 billion to expand its CAR T-cell immunotherapy portfolio and diversify from legacy products.

-- #ChristySanthosh #EvanSeigerman #Bengaluru #Massachusetts #business

✍️ Novo Nordisk acquires Akero Therapeutics for up to $5.2 billion to gain access to a promising liver disease drug candidate.

-- #MaggieFick #MariamSunny #MikeDoustdar #EvanSeigerman #LukasLeu #Denmark #UnitedStates #India #China #Stockholm #Bengaluru #London #business

✍️ Pfizer Inc (NYSE:PFE) is a trending stock in the healthcare sector, with analysts expecting a rally soon. The company recently acquired Metsera, a clinical-stage biopharmaceutical company, and has a strong pipeline of products.

-- #EvanSeigerman #PiotrKowalski #business

✍️ President Trump's deal with Pfizer to lower drug prices includes a three-year exemption from pharmaceutical-specific tariffs, bringing relief to the pharmaceutical industry.

-- #DonaldTrump #AlbertBourla #HowardLutnick #EvanSeigerman #ChrisSchott #DavidRisinger #Washington,DC #OvalOffice #politics

✍️ Scholar Rock's drug apitegromab has been declined by the US FDA due to issues at a third-party manufacturing facility, sending the company's shares down 12%.

-- #PuyaanSingh #SriparnaRoy #EvanSeigerman #ChristySanthosh #BhanviSatija #ShaileshKuber #Bengaluru #Indiana #health

✍️ AbbVie Inc. is a high-growth mega cap stock that can be held for the next 3 years, with a potential upside of nearly 10% due to the resolution of litigation and early market entry of generic Rinvoq.

-- #EvanSeigerman #Illinois #business

✍️ Bristol-Myers Squibb Company is a biopharmaceutical company with a Hold rating from analysts due to stable growth of its new product Cobenfy, but concerns about the effectiveness of its VEGF mechanism.

-- #EvanSeigerman #MattPhipps #business

✍️ Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is a biotechnology company that develops medicines for serious diseases, and analysts are positive about its outlook.

-- #EvanSeigerman #business

✍️ Regeneron Pharmaceuticals, Inc. is a cheap stock to buy for beginners, with a promising outlook due to its recent Phase 3 trials for allergy antibody cocktails.

-- #EvanSeigerman #business

✍️ BioNTech SE, a German biotechnology company, is a top high growth international stock to buy, with a stable COVID-19 vaccine business and emerging pipeline of catalysts.

-- #EvanSeigerman #business

✍️ Eli Lilly and Novo Nordisk are preparing to launch oral obesity drugs in the US, but Lilly's pill produced less weight loss than expected in a recent trial, raising questions about adoption and market share.

-- #DanSkovronsky #MartinHolstLange #EvanSeigerman #MikeDoustdar #US #Denmark #health

✍️ Bristol-Myers Squibb Company is a biopharmaceutical company with a new product, Cobenfy, that has stable growth but failed to meet expectations.

-- #EvanSeigerman #business

✍️ Gilead Sciences, Inc. (NASDAQ:GILD) is a biotech company with a strong analyst consensus rating and a potential upside of 14.19% from current levels.

-- #EvanSeigerman #Trump #business

✍️ Bristol-Myers Squibb Company is considered an undervalued low volatility stock to buy, with a hold rating from BMO Capital analyst Evan Seigerman.

-- #EvanSeigerman #business

✍️ Eli Lilly's obesity pill, orforglipron, underwhelmed Wall Street with its trial data, causing less weight loss and higher side effects than expected. Despite this, analysts believe it could still be a viable competitor in the weight loss drug market.

-- #DavidRicks #Mihail'Misha'Zilbermint #MikeDoustar #EvanSeigerman #DavidRisinger #JaredHolz #Indianapolis #Copenhagen #Bagsvaerd #health

✍️ Gilead Sciences reported flat second-quarter earnings on slightly higher revenue, driven by better-than-expected sales of HIV drugs.

-- #DeenaBeasley #DanielO'Day #EvanSeigerman #AndrewDickinson #BillBerkrot #ChrisReese #business

✍️ Eli Lilly's daily obesity pill has shown promising results in a late-stage trial, helping patients lose over 12% of their body weight, or roughly 27 pounds, at 72 weeks.

-- #Dr.JaimeAlmandoz #Dr.Mihail'Misha'Zilbermint #Dr.AmySheer #KenCuster #EvanSeigerman #Dr.CarolineApovian #SeamusFernandez #Indianapolis #UTSouthwesternMedicalCenter #JohnsHopkinsCommunityPhysicians #UniversityofFlorida #BrighamandWomen'sHospital #health

✍️ AbbVie Inc., a research-based biopharmaceutical company, has lagged behind the broader market over the past 52 weeks, but has outperformed the Invesco Pharmaceuticals ETF and has a promising earnings surprise history.

-- #EvanSeigerman #NeharikaJain #NorthChicago,Illinois #business

✍️ Shares of European drugmakers fell after US President Donald Trump sent letters to major pharmaceutical firms to cut drug prices in the US.

-- #AnkurBanerjee #DonaldTrump #VasuMenon #EvanSeigerman #Singapore #UnitedStates #Europe #business

✍️ Gilead Sciences, a biopharmaceutical company, has outperformed the broader market over the past year, with its shares gaining 47% compared to the S&P 500's 17% rise.

-- #EvanSeigerman #FosterCity,California #business

✍️ The American Society of Clinical Oncology's annual meeting in Chicago is underway, with big pharma deals being announced, including Sanofi's $9 billion acquisition of Blueprint Medicines and Bristol-Myers Squibb's licensing of a cancer drug from BioNTech.

-- #EvanSeigerman #Chicago #health

✍️ Novo Nordisk's CEO steps down as the company struggles to regain its lead in the weight loss drug market, with Eli Lilly's rival treatment gaining ground.

-- #LarsFruergaardJorgensen #DaveRicks #EvanSeigerman #CourtneyBreen #HelgeLund #Copenhagen #Denmark #UnitedStates #health

✍️ Novo Nordisk is searching for a new CEO to replace Lars Fruergaard Jorgensen, and analysts suggest an American leader could be better suited to navigate the company's largest market, the US, amidst the Trump administration's changes to pharmaceutical trade, manufacturing, and regulation.

-- #LarsFruergaardJorgensen #LarsRebienSorensen #MadsOvlisen #DavidMoore #DonaldTrump #DavidRicks #EvanSeigerman #AlexAzar #Denmark #UnitedStates #London #NewYork #Indyansapolis #business

✍️ A US district court has ruled in favor of Acadia Pharmaceuticals in a patent infringement lawsuit against Aurobindo, potentially extending the company's patent protection.

-- #EvanSeigerman #business

✍️ Novo Nordisk's CEO Lars Fruergaard Jorgensen is stepping down due to concerns the company is losing its first-mover advantage in the obesity drug market.

-- #LarsFruergaardJorgensen #EmilyField #LukasLeu #KerryHolford #EvanSeigerman #CarstenLonborgMadsen #MikaelBak #EdEgilinsky #SeamusFernandez #HelgeLund #MarkusManns #TrungHuynh #YuriKhodjamirian #London #Copenhagen #business

✍️ President Trump signs an executive order to lower US drug costs by linking prices to those paid in other developed countries, but experts question its effectiveness and feasibility.

-- #DonaldTrump #JayBhattacharya #RobertF.KennedyJr. #GerardAnderson #LawrenceGostin #TriciaNeuman #LeighPurvis #EvanSeigerman #Washington,DC #Canada #EuropeanUnion #France #Switzerland #health

✍️ Vertex Pharmaceuticals missed quarterly estimates due to lower-than-expected sales of its cystic fibrosis drug Trikafta, despite raising the lower end of its revenue forecast.

-- #ChristySanthosh #EvanSeigerman #SriparnaRoy #MohammedSafiShamsi #Bengaluru #business

✍️ Experts warn that pharmaceutical tariffs could negatively impact the supply of generic drugs, leading to shortages and price increases.

-- #JohnMurphyIII #RenaConti #ArthurWong #EvanSeigerman #KathleenJaeger #DonaldTrump #China #India #UnitedStates #health

✍️ The article discusses the potential risks of a recession in the US and the impact on the stock market, specifically focusing on Eli Lilly and Company (NYSE:LLY) as a potential investment opportunity.

-- #JeromePowell #JoyceChang #EvanSeigerman #business

✍️ Shares in large US and European drugmakers fell due to a potential tariff on pharmaceuticals announced by President Donald Trump.

-- #EvanSeigerman #DonaldTrump #US #Europe #business

✍️ President Trump's plan to impose tariffs on pharmaceuticals imported into the U.S. led to a decline in shares of drugmakers, with U.S.-based companies falling 4% or more and foreign-based companies falling more than 4%.

-- #DonaldTrump #EvanSeigerman #DaveRicks #SanDiego #California #NewYork #China #India #politics

✍️ Health experts are seeing signs of a smaller wave of COVID-19 cases this winter, which could put pressure on Pfizer to find growth from its non-COVID treatments.

-- #MichaelErman #JeffJonas #EvanSeigerman #AlbertBourla #DonaldTrump #JeremyKamil #AndyPekosz #MarcJohnson #health

✍️ Robert F. Kennedy Jr. has been tapped by President-elect Donald Trump to lead the Department of Health and Human Services, sparking concerns in the public health community and among the biotech and pharmaceutical industries.